Comparison of serum PSMA, PSA levels with results of cytogen-356 ProstaScint® scanning in prostatic cancer patients (Q73938167)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9397201%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9397201%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Comparison of serum PSMA, PSA levels with results of cytogen-356 ProstaScint® scanning in prostatic cancer patients (English)

1 reference

10.1002/(SICI)1097-0045(19971201)33:4<281::AID-PROS9>3.0.CO;2-K

https://api.crossref.org/works/10.1002/(SICI)1097-0045(19971201)33:4%3C281::AID-PROS9%3E3.0.CO;2-K

28 November 2024

author name string

G. P. Murphy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

R. T. Maguire

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

B. Rogers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

A. W. Partin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

W. B. Nelp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

M. J. Troychak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

H. Ragde

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

G. M. Kenny

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

R. J. Barren

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

V. A. Bowes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

A. K. Gregorakis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

E. H. Holmes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

A. L. Boynton

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9397201

28 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9397201

28 November 2024

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9397201%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

8 November 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0045(19971201)33:4%3C281::AID-PROS9%3E3.0.CO;2-K

1 reference

10.1002/(SICI)1097-0045(19971201)33:4<281::AID-PROS9>3.0.CO;2-K

https://api.crossref.org/works/10.1002/(SICI)1097-0045(19971201)33:4%3C281::AID-PROS9%3E3.0.CO;2-K

https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0045(19971201)33:4%3C281::AID-PROS9%3E3.0.CO;2-K

28 November 2024

1 reference

10.1002/(SICI)1097-0045(19971201)33:4<281::AID-PROS9>3.0.CO;2-K

https://api.crossref.org/works/10.1002/(SICI)1097-0045(19971201)33:4%3C281::AID-PROS9%3E3.0.CO;2-K

28 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9397201%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9397201%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9397201%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

281-285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9397201%20AND%20SRC:MED&resulttype=core&format=json

Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356)

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Prostate cancer imaging with a new monoclonal antibody: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Disagreement between the Roche Cobas Core and Hybritech TANDEM-E PSA assays when measuring free, complexed and total serum prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Basic principles of ROC analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Prognostic significance of lymph nodal metastases in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Impact of Radical Prostatectomy in the Management of Clinically Localized Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

Cat scanning in staging of prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819971201%2933%3A4%3C281%3A%3AAID-PROS9%3E3.0.CO%3B2-K

International Journal of Cancer

21 January 2018

13

62

552

Troyer

1996

1 reference

10.1002/(SICI)1097-0045(19971201)33:4<281::AID-PROS9>3.0.CO;2-K

https://api.crossref.org/works/10.1002/(SICI)1097-0045(19971201)33:4%3C281::AID-PROS9%3E3.0.CO;2-K

[Validation of the Düsseldorfer screening tool: a trait-based approach to assess psychological distress of cancer patients]

28 November 2024

18

1 reference

10.1002/(SICI)1097-0045(19971201)33:4<281::AID-PROS9>3.0.CO;2-K

https://api.crossref.org/works/10.1002/(SICI)1097-0045(19971201)33:4%3C281::AID-PROS9%3E3.0.CO;2-K

28 November 2024

Identifiers

10.1002/(SICI)1097-0045(19971201)33:4<281::AID-PROS9>3.0.CO;2-K

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9397201%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference